A.C Camargo Cancer Center

Name

A.C Camargo Cancer Center

Legal name

Fundação Antônio Prudente

Website

https://accamargo.org.br

Company type

Private

Founded year

1953

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Oncology Treatment Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Oncology Telemedicine Platforms (HLALAGAH), Surgical Oncology (HLAKAFAG)

Keywords

• Oncology treatment services
• Cancer diagnostic services
• Radiotherapy chemotherapy
• Clinical oncology research
• Cancer rehabilitation services

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Healthcare Services Revenue: Revenue generated from providing comprehensive oncology services including consultations, diagnostic exams, chemotherapy, radiotherapy, surgeries, and other cancer treatments. Services are delivered through multiple units across São Paulo.
2. Health Insurance Reimbursement: The institution accepts multiple health insurance plans (convenios) and receives reimbursement for covered services provided to insured patients.
3. Public Health System (SUS/PROADI-SUS): Participation in Brazilian public health programs including PROADI-SUS, providing diagnostic services under government healthcare initiatives.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels5 records

Core offering

A.C. Camargo Cancer Center delivers comprehensive oncology care across the entire patient journey — prevention, investigation, staging, treatment, palliative care, and rehabilitation — within a single integrated Cancer Center setting. It operates five physical units in São Paulo offering diagnostic medicine, chemotherapy, radiotherapy, robotic surgery, immunotherapy, oncological emergency care, telemedicine, and clinical trials, supported by multidisciplinary reference centers specialized by cancer type and AI-powered digital pathology deployed via a partnership with PathAI.

Product overview

A.C.Camargo Cancer Center operates as a comprehensive Cancer Center platform — not a general hospital — offering the complete oncology journey from prevention through rehabilitation in a single, integrated setting. The core offering centers on the Cancer Center Model, which bundles specialized reference centers by cancer type (e.g., breast, lung, hematological, pediatric tumors), multidisciplinary Tumor Board discussions, navigator nurse support, and on-site diagnostic medicine (pathology, imaging, laboratory). Treatment services include chemotherapy, radiotherapy, robotic surgery, and immunotherapy, alongside a dedicated oncological emergency department. The center runs active clinical studies across multiple cancer types, supported by its CIPE (Centro Internacional de Pesquisa) for basic/translational research and an Innovation Hub for technology development. Patient-facing digital services include a telemedicine platform, online exam results portal, and a Teaching Portal for professional education. The institution's recent partnership with PathAI deploys the AISight AI platform (computer vision for digital pathology) to digitize pathology workflows across Brazil's public health system.

Differentiator

Problem solved

Functional benefit

Products and services

• Medicina Diagnóstica (Diagnostic Medicine) On-site diagnostic services including laboratory tests, imaging, and pathology examinations, integrated within the Cancer Center to support accurate cancer diagnosis and staging for patients across all cancer types.
• Tratamentos Oncológicos (Oncology Treatments) Cancer treatment services including chemotherapy, radiotherapy, robotic surgery, and immunotherapy, delivered by specialized oncology teams within the Cancer Center for diagnosed cancer patients.
• Pronto Socorro Oncológico (Oncological Emergency) Specialized emergency department for cancer patients that accesses the patient's electronic medical record and delivers treatment consistent with their oncology journey.
• Telemedicina (Telemedicine) Remote medical consultation services enabling patients to access specialist oncology care without visiting the facility physically, part of the institution's digital health transformation.
• Centros de Referência (Specialized Reference Centers) Specialized centers organized by cancer type — including Hematological Neoplasms, Sarcomas and Bone Tumors, Colorectal Tumors, Skin Tumors, Head and Neck Tumors, Breast Tumors, Upper Digestive Tract Tumors, Lung and Thorax Tumors, Central Nervous System Tumors, Gynecological Tumors, Neuroendocrine Tumors, Pediatric Tumors, and Urological Tumors — providing type-specific oncology expertise.
• Estudos Clínicos (Clinical Studies / Clinical Trials) Clinical trial program offering patients access to investigational treatments across multiple cancer types, conducted with safety, support, and specialized monitoring across all phases, including sponsored trials.
• Vida Pós-Câncer (Life After Cancer) Post-cancer rehabilitation and survivorship support program helping patients transition and recover after completing active cancer treatment.
• AI-Powered Digital Pathology (AISight Platform Deployment) AI-powered digital pathology service deployed across Brazil's public health system (PROADI-SUS) using the PathAI AISight platform to digitize pathology workflows, enable remote biopsy review, and connect regional laboratories through shared digital infrastructure.

Quantifiable outcome

• 5-year survival rate for lung cancer increased from 10.4% (2000) to 51.1% (2017)
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

One partnership is on record.

• PathAIcoreStrategic or Co-development Partner · 6 May 2026PathAI and A.C.Camargo Cancer Center launched a strategic collaboration in May 2026 to deploy AI-enabled digital pathology across Brazil using the AISight platform. The initiative aims to digitize pathology workflows, connect regional laboratories through shared digital infrastructure, and enable remote biopsy review with centralized expert analysis. The partnership leverages Brazil's public health programs including PROADI-SUS and the Super Cancer Diagnostic Center under the Agora Tem Especialistas program, addressing regional disparities in specialist availability and positioning the model as a scalable framework for AI-driven cancer care in Latin America.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Dana-Farber Cancer Institute: U.S. cancer specialty hospital affiliated with Harvard and integrated with a major academic medical center; comparable as a research-driven, multidisciplinary oncology institution with reference programs by tumor type.
• Memorial Sloan Kettering Cancer Center: U.S.-based dedicated cancer center integrating research, treatment, and survivorship programs; directly comparable as a specialty oncology institution combining reference centers, clinical trials, and outcome tracking.
• MD Anderson Cancer Center: U.S.-based comprehensive cancer center recognized as the international benchmark for the Cancer Center model A.C. Camargo explicitly emulates; comparable across care integration, research, multidisciplinary tumor boards, and outcome-driven oncology.
• European Institute of Oncology (IEO): Milan-based private comprehensive cancer center founded on a similar integrated Cancer Center philosophy; directly comparable as a single-specialty, research-driven oncology institution with multidisciplinary case management.
• Hospital de Amor (formerly Hospital do Câncer de Barretos): Brazil's other leading dedicated oncology hospital network, focused largely on SUS patients with multiple units across Brazil; directly comparable as a Cancer Center-style model serving Brazilian oncology demand at scale.
• Instituto Nacional de Câncer (INCA): Brazil's federal public cancer institute operating under the Ministry of Health, providing oncology treatment, research, and education nationwide; comparable as a national reference for Brazilian cancer care and a counterpart in SUS service delivery.

Broad incumbents

• Hospital Sírio-Libanês: Major Brazilian private hospital based in São Paulo providing high-end oncology, research, and teaching services; competes for the same high-acuity private cancer patients and has similar academic/teaching affiliations.
• Hospital Israelita Albert Einstein: Large Brazilian private hospital network in São Paulo offering a comprehensive oncology program alongside broader specialty care; comparable as a São Paulo-based premium competitor investing heavily in AI, precision medicine, and clinical research.
• Rede D'Or São Luiz: Brazil's largest private hospital network with a meaningful oncology footprint across multiple states; comparable as a Brazilian incumbent expanding comprehensive oncology services and investing in digital health and AI diagnostics.
• Hospital Moinhos de Vento: Brazilian hospital in southern Brazil with a growing oncology line and active AI/digital pathology initiatives; comparable as a domestic competitor pairing premium hospital care with emerging cancer technology programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@ACCamargoCancerCenter
• Facebookfacebook.com/accamargocancercenter
• LinkedInlinkedin.com/company/accamargo
• Instagraminstagram.com/accamargocancercenter
• Xx.com/acccancercenter

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about A.C Camargo Cancer Center